Market Overview

UPDATE: Benchmark Company Initiates Merit Medical Systems with Hold on Limited Visibility

Share:
Related MMSI
Benzinga's Top Upgrades, Downgrades For August 28, 2017
Lightning Round: Jim Cramer Weighs In On Juno Therapeutics, Halliburton And More
Merit Medical - Becton And Bard Deal Looks Nice (Seeking Alpha)

In a report published Thursday, Benchmark Company analyst James Terwilliger initiated coverage on Merit Medical Systems (NASDAQ: MMSI) with a Hold rating and $10.00 price target.

In the report, Terwilliger noted, “Our $10.00 price target represents 20 times our adjusted 2013 EPS estimate of $0.53. We believe that visibility is limited as MMSI reported Q1:13 results that missed analyst estimates and also lowered guidance for 2013. We believe that the lowered guidance for 2013 was driven by a slow-down in their core business, integration issues associated with their recent acquisition of Thomas Medical Products (formerly a unit of GE Healthcare) and lack of visibility regarding new product launches.”

Merit Medical Systems closed on Wednesday at $10.00.

Latest Ratings for MMSI

DateFirmActionFromTo
Oct 2017Canaccord GenuityMaintainsBuy
Aug 2017Raymond JamesDowngradesStrong BuyOutperform
Jul 2017Bank of AmericaInitiates Coverage OnBuy

View More Analyst Ratings for MMSI
View the Latest Analyst Ratings

Posted-In: Benchmark CompanyAnalyst Color Initiation Analyst Ratings

 

Related Articles (MMSI)

View Comments and Join the Discussion!

Partner Center